• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SPI MCRYL+ UNI 18IN 4-0 SA PS-2 PRM; SUTURE, SURGICAL, ABSORBABLE, POLYGLCOLIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SPI MCRYL+ UNI 18IN 4-0 SA PS-2 PRM; SUTURE, SURGICAL, ABSORBABLE, POLYGLCOLIC ACID Back to Search Results
Model Number SXMP1B118
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/06/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Additional information was requested, and the following was obtained: please provide the lot number for the stratafix spiral monocryl plus (product code: sxmp1b118).Lot #rhbbla.Please provide the lot number for the silk suture (product code k834h).Lot #rcbbka.When did the sutures broke (in the package, during removal from package, during handling or during use on the patient)? please specify for both of the two sutures.During use on the patient for both sutures attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Trade name - stratafix¿, active ingredient(s)- triclosan, dosage form - suture/solid/parenteral, strength - = 2360 ug /m.Events reported via: 2210968-2021-10738.
 
Event or Problem Description
It was reported that a patient underwent a coronary procedure on (b)(6) 2021 and barbed suture was used.During the procedure, the suture broke.Another like device was used to complete the surgery.There were no patient consequences reported.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint #(b)(4).Date sent to the fda: 11/24/2021.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H3: investigational narrative: visual analysis of the returned product revealed that one opened sample product code sxmp1b118 was received to ethicon inc for evaluation.Upon visual inspection of the returned sample, the suture was to be damaged at the surface, body fluids and the barbs were to be damaged at the tips.In addition, the end was observed cut.After further evaluation crimping marks were observed on the surface suture possibly from a surgical instrument.The product code sxmp1b118 contains absorbable suture, as the sample was received open, the time of exposure to the environment could not be determined and a functional test cannot be performed.As with any device, care should be taken to avoid damage to the strand when handling.Avoid the crushing or crimping action of the surgical instruments, such as needle holders and forceps.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Trade name - stratafix¿ active ingredient(s)- triclosan dosage form - suture/solid/parenteral strength: 2360 g /m.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SPI MCRYL+ UNI 18IN 4-0 SA PS-2 PRM
Common Device Name
SUTURE, SURGICAL, ABSORBABLE, POLYGLCOLIC ACID
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON, INC. SAN LORENZO
road 183, km. 8.3
san lorenzo PR
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key12738372
Report Number2210968-2021-10501
Device Sequence Number4099481
Product Code GAM
UDI-Device Identifier10705031236707
UDI-Public10705031236707
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
N12159
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2023
Device Model NumberSXMP1B118
Device Catalogue NumberSXMP1B118
Device Lot NumberRHBBLA
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/27/2021
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/06/2021
Supplement Date Received by Manufacturer10/27/2021
Initial Report FDA Received Date11/02/2021
Supplement Report FDA Received Date11/24/2021
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/12/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-